Company Profile
Bonus BioGroup Ltd., a clinical-stage biotechnology company develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial in a preclinical stage for the treatment of bone augmentation in osteoporosis patients.
It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage
Including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Incorporated in 1981, Bonus BioGroup is headquartered in Haifa, Israel.